Class Action Lawsuit Filed Against Hims & Hers Health Following FTC Allegations
Pomerantz LLP has announced a class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) regarding potential securities fraud and unlawful business practices. The legal action follows an investigation by the Federal Trade Commission (FTC), which alleges that the telehealth provider mishandled sensitive consumer health data by sharing it with third-party advertising platforms like Meta Platforms and Snap Inc. The FTC further claims that Hims & Hers engaged in deceptive billing and cancellation practices, including charging consumers for prescriptions before they could consult with medical providers. These allegations led to a significant market reaction on July 29, 2026, when the company's stock price plummeted by over 14%. Investors seeking to be appointed as lead plaintiffs have until November 2, 2026, to submit their requests.
Topics: Consumer Protection Data Privacy FTC Investigation Securities Fraud